Search Results - "Matias Guiu, J."

Should we expect neurological symptoms in the SARS-CoV-2 epidemic? by Matías-Guiu, J, Gomez-Pinedo, U, Montero-Escribano, P, Gomez-Iglesias, P, Porta-Etessam, J, Matias-Guiu, J A

“…There is growing evidence that SARS-CoV-2 can gain access to the central nervous system (CNS). We revise the literature on coronavirus infection of the CNS…”
Get full text

Management of neurological care during the COVID-19 pandemic by Matías-Guiu, J, Porta-Etessam, J, Lopez-Valdes, E, Garcia-Morales, I, Guerrero-Solá, A, Matias-Guiu, J A

“…The COVID-19 epidemic has led to the need for unprecedented decisions to be made to maintain the provision of neurological care. This article addresses…”
Get full text

Vitamin D and remyelination in multiple sclerosis by Matías-Guíu, J, Oreja-Guevara, C, Matias-Guiu, J A, Gomez-Pinedo, U

“…Several studies have found an association between multiple sclerosis and vitamin D (VD) deficiency, which suggests that VD may play a role in the immune…”
Get full text

Cerebrospinal fluid cytotoxicity does not affect survival in amyotrophic lateral sclerosis by Galán, L., Matías‐Guiu, J., Matias‐Guiu, J. A., Yáñez, M., Pytel, V., Guerrero‐Sola, A., Vela‐Souto, A., Arranz‐Tagarro, J. A., Gómez‐Pinedo, U., García, A. G.

“…Objectives Cerebrospinal fluid (CSF) from some patients with amyotrophic lateral sclerosis (ALS) has been demonstrated to significantly reduce the neuronal…”
Get full text

Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis and sample size by Galan, L, Matias-Guiu, J A, Guerrero-Sola, A, Matias-Guiu, J

Get full text

FDG-PET/CT or MRI for the Diagnosis of Primary Progressive Aphasia? by Matias-Guiu, J A, Cabrera-Martín, M N, Matías-Guiu, J, Carreras, J L

Get full text

The role of scientific journal editors during the COVID-19 pandemic by Matias-Guiu, J.

Get full text

Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey by Matías-Guiu, J, Matias-Guiu, J A, Alvarez-Sabin, J, Ramon Ara, J, Arenillas, J, Casado-Naranjo, I, Castellanos, M, Jimenez-Hernandez, M D, Lainez-Andres, J M, Moral, E, Morales, A, Rodriguez-Antigüedad, A, Segura, T, Serrano-Castro, P, Diez-Tejedor, E

“…The COVID-19 pandemic will give rise to long-term changes in neurological care, which are not easily predictable. A key informant survey was used to enquire…”
Get full text

Validation of the Spanish version of Addenbrooke's Cognitive Examination III for diagnosing dementia by Matias-Guiu, J A, Fernández de Bobadilla, R, Escudero, G, Pérez-Pérez, J, Cortés, A, Morenas-Rodríguez, E, Valles-Salgado, M, Moreno-Ramos, T, Kulisevsky, J, Matías-Guiu, J

“…Addenbrooke's Cognitive Examination is a screening test used to diagnose dementia. The third edition of this test (ACE-III) was recently developed. The aim of…”
Get more information

Topography of primitive reflexes in dementia: an F-18 fluorodeoxyglucose positron emission tomography study by Matias-Guiu, J. A., Cabrera-Martín, M. N., Fernádez-Matarrubia, M., Moreno-Ramos, T., Valles-Salgado, M., Porta-Etessam, J., Carreras, J. L., Matias-Guiu, J.

“…Background and purpose Although primitive reflexes (PRs) are inhibited during the first years of childhood, they may reappear with brain injury. PRs have been…”
Get full text

NG2 and GFAP co-expression after differentiation in cells transfected with mutant GFAP and in undifferentiated glioma cells by Gómez-Pinedo, U, Sirerol-Piquer, S, Durán-Moreno, M, Matias-Guiu, J A, Barcia, J A, García-Verdugo, J M, Matias-Guiu, J

“…INTRODUCTIONAlexander disease is a rare disorder caused by mutations in the gene coding for glial fibrillary acidic protein (GFAP). In a previous study,…”
Get full text

Role of deep brain stimulation therapy in the magnetic resonance-guided high-frequency focused ultrasound era: current situation and future prospects by Fernandez-Garcia, C, Alonso-Frech, F, Monje, M H G, Matias-Guiu, J

“…: Deep brain stimulation (DBS) is a well-established treatment of movement disorders; but recently there has been an increasing trend toward the ablative…”
Get more information

Cell therapy as a treatment strategy in amyotrophic lateral sclerosis by L. Moreno-Jiménez, M.S. Benito-Martín, A. Abad-Fernández, B. Selma-Calvo, N. Fernandez-Cucho, J.A. Matias-Guiu, L. Galán-Davila, A. Guerrero-Sola, U. Gómez-Pinedo, J. Matias-Guiu

“…Cell therapy and tissue engineering are promising therapeutic strategies for such neurodegenerative diseases as amyotrophic lateral sclerosis (ALS). Studies of…”
Get full text

Large artery occlusion diagnosed by computed tomography angiography in acute ischaemic stroke: frequency, predictive factors, and safety by Matias-Guiu, J A, Serna-Candel, C, Espejo-Domínguez, J M, Fernández-Matarrubia, M, Simal, P, Matias-Guiu, J

“…Demonstrating artery occlusion in ischaemic stroke has gained importance due to the increasing availability of endovascular therapies. This study evaluates the…”
Get more information

The role of scientific journal editors during the COVID-19 pandemic by Matias-Guiu, J

Get full text

Suboptimal interventional conditions for the occlusion of ruptured intracranial aneurysms do not increase periprocedural complications and poor clinical outcomes by Matías-Guiu, J. A., Avecillas-Chasín, J., Barcia, J. A, Moreu, M., López-Ibor, L.

“…Background and objective Occluding a ruptured intracranial aneurysm as early as possible may entail certain periprocedural conditions that compromise the…”
Get full text

Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily by Diener, H C, Matias-Guiu, J, Hartung, E, Pfaffenrath, V, Ludin, H P, Nappi, G, De Beukelaar, F

“…This was a phase-IV double-blind equivalence trial designed to assess the efficacy and tolerability of two doses of flunarizine (10 mg o.d.=FLU 10 mg and 5 mg…”
Get more information

La alteración de la mielina en la enfermedad de Alexander by Gómez-Pinedo, U, Duran-Moreno, M, Sirerol-Piquer, S, Matias-Guiu, J

“…Resumen Introducción La enfermedad de Alexander (AxD) es una leucodistrofia. Su base patológica, junto a la pérdida de mielina, es la aparición de los cuerpos…”
Get full text

Re: Scholten et al. Nuclear β-catenin is a molecular feature of type I endometrial carcinoma. J Pathol 2003; 201: 460-465 by Moreno-Bueno, G, Hardisson, D, Prat, J, Matías-Guiu, J, Palacios, J

Get full text

El papel del editor de una revista científica durante la pandemia del Covid-19 by Matias-Guiu, J.

Get full text